Histological approach to neuronal and mixed neuronal-glial tumors of the central nervous system
暂无分享,去创建一个
[1] David T. W. Jones,et al. Molecularly defined diffuse leptomeningeal glioneuronal tumor (DLGNT) comprises two subgroups with distinct clinical and genetic features , 2018, Acta Neuropathologica.
[2] Shaowu Li,et al. Histopathological, molecular, clinical and radiological characterization of rosette-forming glioneuronal tumor in the central nervous system , 2017, Oncotarget.
[3] Shih-Chieh Lin,et al. Thyroid transcription factor-1 distinguishes subependymal giant cell astrocytoma from its mimics and supports its cell origin from the progenitor cells in the medial ganglionic eminence , 2017, Modern Pathology.
[4] David T. W. Jones,et al. Polymorphous low-grade neuroepithelial tumor of the young (PLNTY): an epileptogenic neoplasm with oligodendroglioma-like components, aberrant CD34 expression, and genetic alterations involving the MAP kinase pathway , 2016, Acta Neuropathologica.
[5] David T. W. Jones,et al. Droplet digital PCR is a powerful technique to demonstrate frequent FGFR1 duplication in dysembryoplastic neuroepithelial tumors , 2016, Oncotarget.
[6] David T. W. Jones,et al. Germline and somatic FGFR1 abnormalities in dysembryoplastic neuroepithelial tumors , 2016, Acta Neuropathologica.
[7] S. Nobusawa,et al. SLC44A1–PRKCA fusion in papillary and rosette-forming glioneuronal tumors , 2016, Journal of Clinical Neuroscience.
[8] Heather L. Mulder,et al. Genetic alterations in uncommon low-grade neuroepithelial tumors: BRAF, FGFR1, and MYB mutations occur at high frequency and align with morphology , 2016, Acta Neuropathologica.
[9] P. Varlet,et al. Papillary glioneuronal tumors: histological and molecular characteristics and diagnostic value of SLC44A1-PRKCA fusion , 2015, Acta Neuropathologica Communications.
[10] I. Vajtai,et al. Consistent nuclear expression of thyroid transcription factor 1 in subependymal giant cell astrocytomas suggests lineage-restricted histogenesis. , 2015, Clinical neuropathology.
[11] D. Figarella-Branger,et al. Dysembryoplastic Neuroepithelial Tumors Share with Pleomorphic Xanthoastrocytomas and Gangliogliomas BRAFV600E Mutation and Expression , 2013, Brain pathology.
[12] M. Rosenblum,et al. Identification of a Novel, Recurrent SLC44A1‐PRKCA Fusion in Papillary Glioneuronal Tumor , 2013, Brain pathology.
[13] M. Preusser,et al. Mutant BRAF V600E protein in ganglioglioma is predominantly expressed by neuronal tumor cells , 2013, Acta Neuropathologica.
[14] L. Capelle,et al. Hemorrhagic papillary glioneuronal tumor mimicking cavernoma: Two case reports , 2013, Clinical Neurology and Neurosurgery.
[15] V. P. Collins,et al. Absence of KIAA1549-BRAF fusion in rosette-forming glioneuronal tumors of the fourth ventricle (RGNT) , 2012, Journal of Neuro-Oncology.
[16] A. Jouvet,et al. Prognostic Factors in Central Neurocytomas: A Multicenter Study of 71 Cases , 2012, The American journal of surgical pathology.
[17] K. Aldape,et al. Recurrent PIK3CA mutations in rosette-forming glioneuronal tumor , 2012, Acta Neuropathologica.
[18] T. Tihan,et al. Pathologic Characteristics of Pediatric Intracranial Pilocytic Astrocytomas and Their Impact on Outcome in 3 Countries: A Multi-institutional Study , 2012, The American journal of surgical pathology.
[19] A. Waha,et al. Analysis of KIAA1549‐BRAF fusion status in a case of rosette‐forming glioneuronal tumor of the fourth ventricle (RGNT) , 2011, Neuropathology : official journal of the Japanese Society of Neuropathology.
[20] P. Tsitsopoulos,et al. A 57‐YEAR‐OLD FEMALE WITH A CEREBELLAR MASS , 2011, Brain pathology.
[21] Kirsten Schmieder,et al. Analysis of BRAF V600E mutation in 1,320 nervous system tumors reveals high mutation frequencies in pleomorphic xanthoastrocytoma, ganglioglioma and extra-cerebellar pilocytic astrocytoma , 2011, Acta Neuropathologica.
[22] J. Biegel,et al. Activating mutations in BRAF characterize a spectrum of pediatric low-grade gliomas. , 2010, Neuro-oncology.
[23] M. Fassan,et al. Diffuse Leptomeningeal Glioneuronal Tumors: A New Entity? , 2010, Brain pathology.
[24] M. Fujiki,et al. A rosette-forming glioneuronal tumor of the spinal cord: the first case of a rosette-forming glioneuronal tumor originating from the spinal cord. , 2009, Human pathology.
[25] B. Scheithauer,et al. ROSETTE‐FORMING GLIONEURONAL TUMOR: REPORT OF A CHIASMAL‐OPTIC NERVE EXAMPLE IN NEUROFIBROMATOSIS TYPE 1 SPECIAL PATHOLOGY REPORT , 2009, Neurosurgery.
[26] K. Ganesan,et al. Non-infantile variant of desmoplastic ganglioglioma: a report of 2 cases , 2006, Pediatric Radiology.
[27] I. Pommepuy,et al. A Report of a Desmoplastic Ganglioglioma in a 12-year-old Girl with Review of the Literature , 2006, Journal of Neuro-Oncology.
[28] R. Fimmers,et al. Supratentorial gangliogliomas: Histopathologic grading and tumor recurrence in 184 patients with a median follow‐up of 8 years , 2004, Cancer.
[29] I. Blümcke,et al. Gangliogliomas: An Intriguing Tumor Entity Associated With Focal Epilepsies , 2002, Journal of neuropathology and experimental neurology.
[30] B. Scheithauer,et al. A Rosette-Forming Glioneuronal Tumor of the Fourth Ventricle: Infratentorial Form of Dysembryoplastic Neuroepithelial Tumor? , 2002, The American journal of surgical pathology.
[31] D. Brat,et al. Extraventricular Neurocytomas: Pathologic Features and Clinical Outcome , 2001, The American journal of surgical pathology.
[32] R. McLendon,et al. March 2000: A 16 year old female with a cerebellar mass. , 2001, Brain pathology.
[33] Peter T. Nelson. Pathology of Tumors of the Central Nervous System , 2001 .
[34] T. Hirose. Dysembryoplastic neuroepithelial tumor , 1999 .
[35] Rajesh C. Dash,et al. Malignant supratentorial ganglioglioma (ganglion cell-giant cell glioblastoma): a case report and review of the literature. , 1999, Archives of pathology & laboratory medicine.
[36] R. McLendon,et al. Papillary glioneuronal tumor: a new variant of mixed neuronal-glial neoplasm. , 1998, The American journal of surgical pathology.
[37] Anderson,et al. Expression of neuronal markers in oligodendrogliomas: an immunohistochemical study , 1998, Neuropathology and applied neurobiology.
[38] B. Scheithauer,et al. Composite pleomorphic xanthoastrocytoma and ganglioglioma: report of four cases and review of the literature. , 1997, The American journal of surgical pathology.
[39] P. Burger,et al. Extraventricular neoplasms with neurocytoma features. A clinicopathological study of 11 cases. , 1997, The American journal of surgical pathology.
[40] S. Vandenberg. Desmoplastic Infantile Ganglioglioma and Desmoplastic Cerebral Astrocytoma of Infancy , 1993, Brain pathology.
[41] R. McLendon,et al. MRI of gangliocytoma of cerebellum and spinal cord. , 1993, Journal of computer assisted tomography.
[42] T. Südhof,et al. Histogenesis and differentiation potential of central neurocytomas. , 1991, Laboratory investigation; a journal of technical methods and pathology.
[43] J. Simpson. Somatic and Visceral Sensory Mechanisms , 1978 .
[44] F. Heppner,et al. The evolution of the anaplastic cerebellar liponeurocytoma: case report and review of the literature. , 2015, Clinical neuropathology.
[45] D. Brat,et al. Neuronal and Glioneuronal Neoplasms , 2010 .
[46] D. Louis. WHO classification of tumours of the central nervous system , 2007 .
[47] M. Bergmann,et al. Dysembryoplastic neuroepithelial tumour of the cerebellum , 2004, Acta Neuropathologica.
[48] S. Vandenberg,et al. Tuber and subependymal giant cell astrocytoma associated with tuberous sclerosis: an immunohistochemical, ultrastructural, and immunoelectron microscopic study , 2004, Acta Neuropathologica.
[49] M. Bergmann,et al. Desmoplastic ganglioglioma: report of two non-infantile cases , 2004, Acta Neuropathologica.
[50] R. Sciot,et al. Desmoplastic Infantile Ganglioglioma: A Potentially Malignant Tumor? , 2002, The American journal of surgical pathology.